Header Logo

Katherine Ruiz De Luzuriaga

Concepts (251)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV-1
34
2022
708
5.980
Why?
HIV Infections
38
2022
921
5.770
Why?
Herpesvirus 4, Human
19
2020
181
3.470
Why?
Anti-Retroviral Agents
14
2019
73
2.590
Why?
Infectious Disease Transmission, Vertical
14
2020
71
2.380
Why?
Infectious Mononucleosis
10
2017
35
1.800
Why?
CD8-Positive T-Lymphocytes
12
2020
646
1.720
Why?
Anti-HIV Agents
8
2020
155
1.700
Why?
DNA, Viral
12
2020
228
1.700
Why?
Proviruses
5
2021
25
1.580
Why?
Epstein-Barr Virus Infections
6
2019
90
1.420
Why?
Genetic Variation
7
2021
366
1.210
Why?
Receptors, Antigen, T-Cell
6
2021
279
1.190
Why?
Viral Load
15
2022
229
1.190
Why?
RNA, Viral
9
2020
266
1.100
Why?
Viral Matrix Proteins
5
2017
51
1.090
Why?
B-Lymphocytes
8
2016
550
1.070
Why?
Immunologic Memory
9
2017
276
1.050
Why?
CD4-Positive T-Lymphocytes
7
2019
609
1.050
Why?
HIV Antibodies
7
2020
141
0.990
Why?
Antiretroviral Therapy, Highly Active
9
2020
94
0.960
Why?
Virus Latency
7
2019
28
0.930
Why?
Infant
21
2020
1527
0.890
Why?
Brain
4
2021
1489
0.840
Why?
HIV Seropositivity
1
2022
82
0.770
Why?
Phylogeny
9
2022
332
0.770
Why?
Pregnancy Complications, Infectious
4
2017
62
0.740
Why?
Vaccines
1
2022
97
0.710
Why?
Secondary Prevention
3
2016
153
0.710
Why?
Antigens, Viral
3
2020
131
0.710
Why?
Immunodominant Epitopes
3
2020
57
0.710
Why?
Spleen
1
2021
485
0.690
Why?
env Gene Products, Human Immunodeficiency Virus
4
2018
56
0.670
Why?
Receptors, Antigen, T-Cell, alpha-beta
2
2020
112
0.650
Why?
Adolescent
21
2022
5930
0.610
Why?
Humans
59
2022
59495
0.590
Why?
Viral Tropism
3
2018
55
0.570
Why?
Recombination, Genetic
2
2020
236
0.550
Why?
Infant, Newborn
12
2022
1311
0.540
Why?
Sequence Analysis, DNA
8
2021
397
0.530
Why?
Virus Replication
7
2017
304
0.520
Why?
Influenza A virus
4
2017
117
0.520
Why?
Virus Integration
1
2016
32
0.510
Why?
HIV Envelope Protein gp120
3
2018
139
0.510
Why?
Macrophages
5
2022
1007
0.500
Why?
Immunotherapy
2
2021
231
0.500
Why?
Epitopes, T-Lymphocyte
5
2019
177
0.490
Why?
Leukocytes, Mononuclear
7
2020
238
0.470
Why?
Child, Preschool
12
2020
1839
0.460
Why?
Oropharynx
1
2014
12
0.450
Why?
CD4 Antigens
2
2018
156
0.440
Why?
Immunoglobulin G
4
2020
452
0.410
Why?
T-Lymphocytes, Cytotoxic
3
2019
165
0.370
Why?
AIDS Vaccines
3
2012
67
0.370
Why?
Viremia
3
2015
44
0.370
Why?
Antibodies, Viral
3
2022
308
0.360
Why?
HIV Envelope Protein gp41
1
2020
22
0.350
Why?
Pregnancy
8
2017
2355
0.340
Why?
Genome, Viral
2
2018
121
0.340
Why?
Software
2
2021
367
0.330
Why?
Major Histocompatibility Complex
1
2020
87
0.330
Why?
Immediate-Early Proteins
1
2019
44
0.330
Why?
Complementarity Determining Regions
1
2019
37
0.330
Why?
Genes, env
3
2021
15
0.330
Why?
Female
26
2020
30908
0.320
Why?
HIV
1
2019
69
0.310
Why?
Trans-Activators
1
2019
295
0.290
Why?
CD4 Lymphocyte Count
5
2017
92
0.290
Why?
Nervous System Diseases
1
2018
97
0.280
Why?
Genes, Immunoglobulin
2
2007
32
0.270
Why?
Antibodies, Neutralizing
2
2018
192
0.270
Why?
Acquired Immunodeficiency Syndrome
1
2017
137
0.270
Why?
High-Throughput Nucleotide Sequencing
3
2021
250
0.270
Why?
Receptors, CCR5
3
2018
57
0.270
Why?
Influenza, Human
1
2017
193
0.250
Why?
Child
7
2020
4304
0.240
Why?
Mutation
6
2017
2429
0.240
Why?
Cytomegalovirus Infections
1
2015
69
0.230
Why?
HLA-A2 Antigen
4
2019
65
0.230
Why?
Molecular Sequence Data
6
2014
1979
0.230
Why?
Male
19
2020
27561
0.220
Why?
Evolution, Molecular
1
2015
291
0.220
Why?
Membrane Glycoproteins
1
2016
669
0.220
Why?
Adult
16
2018
15783
0.210
Why?
Meninges
1
2022
10
0.210
Why?
Disease Reservoirs
1
2012
8
0.210
Why?
Transcriptome
1
2015
326
0.200
Why?
Young Adult
6
2019
4329
0.200
Why?
Cluster Analysis
2
2021
250
0.200
Why?
Amino Acids
1
2022
141
0.190
Why?
Infant, Newborn, Diseases
1
2011
33
0.190
Why?
Cross Reactions
3
2017
123
0.190
Why?
Hepatitis B Vaccines
1
2010
13
0.170
Why?
Amino Acid Sequence
4
2019
1582
0.170
Why?
Proteomics
1
2022
252
0.170
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2009
526
0.170
Why?
Hepatitis B
1
2010
28
0.170
Why?
Acute Disease
4
2016
659
0.170
Why?
Sustained Virologic Response
2
2020
10
0.170
Why?
T-Lymphocytes
2
2022
965
0.170
Why?
Apoptosis Regulatory Proteins
1
2010
148
0.170
Why?
AIDS Serodiagnosis
1
2009
19
0.160
Why?
Drug Therapy, Combination
3
2016
436
0.160
Why?
Antigens, CD
1
2010
344
0.160
Why?
Enzyme-Linked Immunosorbent Assay
3
2020
455
0.160
Why?
Time Factors
5
2014
3579
0.150
Why?
HIV Core Protein p24
1
2008
17
0.150
Why?
HIV Antigens
1
2008
20
0.150
Why?
Peptide Fragments
3
2019
353
0.150
Why?
Computational Biology
2
2021
325
0.150
Why?
gag Gene Products, Human Immunodeficiency Virus
1
2008
36
0.150
Why?
Models, Immunological
1
2007
79
0.140
Why?
Base Sequence
4
2016
1313
0.130
Why?
Lymphocyte Activation
4
2017
741
0.130
Why?
Orthomyxoviridae
1
2005
26
0.130
Why?
Early Medical Intervention
1
2015
17
0.120
Why?
Milk, Human
1
2006
94
0.120
Why?
Viral Vaccines
1
2015
49
0.120
Why?
Computer Simulation
1
2007
455
0.120
Why?
Lymphocytes
1
2005
194
0.120
Why?
Genotype
3
2018
642
0.120
Why?
Gene Expression
4
2018
810
0.120
Why?
Reverse Transcriptase Inhibitors
2
2002
28
0.110
Why?
nef Gene Products, Human Immunodeficiency Virus
2
2019
20
0.110
Why?
B-Lymphocyte Subsets
1
2003
48
0.110
Why?
Pediatrics
1
2006
266
0.110
Why?
Mothers
3
2015
261
0.110
Why?
Treatment Outcome
5
2016
5183
0.110
Why?
Burkitt Lymphoma
1
2003
56
0.110
Why?
Seroepidemiologic Studies
1
2022
48
0.100
Why?
Bayes Theorem
1
2022
108
0.100
Why?
Neonatal Screening
1
2022
96
0.100
Why?
Interferon-gamma
2
2017
539
0.090
Why?
HIV Envelope Protein gp160
1
2020
6
0.090
Why?
Neutralization Tests
2
2018
126
0.090
Why?
Flow Cytometry
3
2018
671
0.090
Why?
Cohort Studies
3
2019
2442
0.080
Why?
Poxviridae
1
2009
5
0.080
Why?
Cell Proliferation
3
2010
945
0.080
Why?
Longitudinal Studies
2
2016
1225
0.080
Why?
DNA, Complementary
2
2012
166
0.080
Why?
pol Gene Products, Human Immunodeficiency Virus
1
2019
4
0.080
Why?
Retrospective Studies
2
2022
6008
0.080
Why?
Polymerase Chain Reaction
1
2020
500
0.080
Why?
Receptors, Virus
1
2018
83
0.080
Why?
Puerto Rico
1
2019
227
0.080
Why?
Immunity, Heterologous
1
2017
11
0.070
Why?
Open Reading Frames
1
2018
82
0.070
Why?
Seroconversion
1
2017
4
0.070
Why?
Convalescence
1
2016
17
0.070
Why?
Blood-Brain Barrier
1
2017
82
0.070
Why?
Virion
1
2017
117
0.070
Why?
Primary Cell Culture
1
2016
75
0.070
Why?
Infant Mortality
1
2016
19
0.070
Why?
Sequence Alignment
1
2016
290
0.070
Why?
DNA Copy Number Variations
1
2016
65
0.060
Why?
Receptors, Interleukin-7
1
2015
16
0.060
Why?
Remission Induction
1
2016
137
0.060
Why?
ADP-ribosyl Cyclase 1
1
2015
29
0.060
Why?
Developing Countries
1
2016
84
0.060
Why?
Time-to-Treatment
1
2016
101
0.060
Why?
Phagocytosis
1
2016
252
0.060
Why?
Genomics
1
2018
314
0.060
Why?
Monocytes
1
2016
351
0.060
Why?
Host-Pathogen Interactions
1
2016
239
0.060
Why?
Epitopes
2
2005
298
0.060
Why?
Cytomegalovirus
1
2015
88
0.060
Why?
In Vitro Techniques
2
2005
475
0.060
Why?
Breast Feeding
1
2016
138
0.060
Why?
Case-Control Studies
1
2016
1063
0.060
Why?
Chronic Disease
1
2016
735
0.050
Why?
Lopinavir
1
2012
5
0.050
Why?
Severity of Illness Index
1
2017
1449
0.050
Why?
Cell Line, Tumor
1
2016
1373
0.050
Why?
Ritonavir
1
2012
14
0.050
Why?
Antibodies
1
2012
177
0.050
Why?
Risk
1
2012
372
0.050
Why?
Vaccines, Synthetic
1
2011
68
0.050
Why?
Cell Line
2
2018
2015
0.050
Why?
HIV Protease Inhibitors
1
2012
106
0.050
Why?
Clone Cells
1
2010
106
0.040
Why?
Autoimmune Diseases
1
2012
224
0.040
Why?
United States
2
2019
7511
0.040
Why?
Pharyngitis
1
2010
12
0.040
Why?
Programmed Cell Death 1 Receptor
1
2010
56
0.040
Why?
Hepatitis B Antibodies
1
2010
8
0.040
Why?
Streptococcus pyogenes
1
2010
27
0.040
Why?
Hepatitis B Surface Antigens
1
2010
16
0.040
Why?
HEK293 Cells
1
2012
577
0.040
Why?
Oligopeptides
1
2010
134
0.040
Why?
Streptococcal Infections
1
2010
77
0.040
Why?
Up-Regulation
1
2010
364
0.040
Why?
Vaccination
1
2011
337
0.040
Why?
Adrenal Cortex Hormones
1
2010
154
0.040
Why?
Receptors, CXCR4
1
2018
32
0.040
Why?
Virus Physiological Phenomena
1
2007
7
0.040
Why?
Palatine Tonsil
1
2007
10
0.040
Why?
Immunoglobulin D
1
2007
7
0.040
Why?
Virus Activation
1
2007
24
0.040
Why?
Tumor Necrosis Factor Receptor Superfamily, Member 7
1
2007
23
0.040
Why?
Stochastic Processes
1
2007
26
0.040
Why?
Transcription Factors
1
2015
1457
0.040
Why?
Middle Aged
2
2017
16275
0.040
Why?
Immunoglobulin M
1
2007
112
0.040
Why?
Diagnosis, Differential
1
2010
900
0.040
Why?
Antiviral Agents
1
2010
314
0.040
Why?
Cytotoxicity, Immunologic
1
2007
142
0.040
Why?
Mutagenesis
1
2007
129
0.040
Why?
Amino Acid Substitution
1
2008
253
0.030
Why?
Protein Multimerization
1
2018
167
0.030
Why?
Africa South of the Sahara
1
2006
17
0.030
Why?
Genetic Vectors
1
2012
813
0.030
Why?
HeLa Cells
1
2008
527
0.030
Why?
Genes, nef
1
2005
6
0.030
Why?
Macrophage Inflammatory Proteins
1
2005
11
0.030
Why?
Chemokine CCL4
1
2005
14
0.030
Why?
Genes, gag
1
2005
11
0.030
Why?
Transfection
1
2008
674
0.030
Why?
Cells, Cultured
1
2010
2104
0.030
Why?
Gene Products, nef
1
2005
14
0.030
Why?
Genes, MHC Class I
1
2005
28
0.030
Why?
K562 Cells
1
2005
58
0.030
Why?
Gene Products, gag
1
2005
65
0.030
Why?
Selection, Genetic
1
2005
69
0.030
Why?
DNA Primers
1
2005
291
0.030
Why?
Sequence Homology, Amino Acid
1
2005
357
0.030
Why?
RNA Stability
1
2015
93
0.030
Why?
Reproducibility of Results
1
2009
1551
0.030
Why?
Recombinant Proteins
1
2006
694
0.030
Why?
Epstein-Barr Virus Nuclear Antigens
1
2003
18
0.030
Why?
Genes, Viral
1
2003
56
0.030
Why?
Immunophenotyping
1
2004
191
0.030
Why?
Dose-Response Relationship, Drug
1
2005
809
0.030
Why?
Withholding Treatment
1
2013
39
0.030
Why?
Chi-Square Distribution
1
2004
403
0.030
Why?
Protein Binding
1
2018
1551
0.030
Why?
Recurrence
1
2015
578
0.030
Why?
Drug Resistance, Viral
1
2004
155
0.030
Why?
Prevalence
1
2006
1281
0.030
Why?
Cell Division
1
2003
443
0.030
Why?
Peptides
1
2005
549
0.020
Why?
Prospective Studies
1
2009
3101
0.020
Why?
Logistic Models
1
2004
1252
0.020
Why?
Age Factors
1
2014
1518
0.020
Why?
Phenotype
1
2003
1157
0.020
Why?
Follow-Up Studies
1
2015
2329
0.020
Why?
Immunization
1
2009
127
0.020
Why?
Models, Biological
1
2003
1142
0.020
Why?
Cross-Sectional Studies
1
2014
2468
0.020
Why?
Risk Factors
1
2014
5015
0.010
Why?
Animals
1
2006
19647
0.010
Why?
Ruiz De Luzuriaga's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (251)
Explore
_
Co-Authors (19)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_